Other News To Note
Friday, January 27, 2012
Hemispherx Biopharma Inc., of Philadelphia, gained regulatory approval in Argentina for genital wart drug Alferon N Injection, which will be marketed under the trade name Naturaferon. The product will be sold by Hemispherx's Latin American partner GP Pharm SA. Alferon N Injection, a natural interferon, is already FDA approved.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.